SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending heavily as the community anticipates major clinical trial milestones and a potential short squeeze, with investors debating the company's valuation and the outcome of the ongoing REGAL trial. Bulls are pointing to high institutional interest and the potential for a buyout, while a vocal group of bears warns of high risk and potential dilution.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market interest as investors react to the potential win of a major Japanese government J-LEO contract and the company's competitive positioning against Starlink. The community is actively discussing a possible short squeeze and the strategic implications of partnerships as they monitor institutional positioning and upcoming launch milestones.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is seeing heightened activity as investors weigh its deep valuation and strong free cash flow against persistent concerns over broadband subscriber losses and intense competition from satellite internet. The community remains divided, with some betting on a rebound driven by theme park growth, sports broadcasting, and dividend reliability, while others express frustration over the stock's long-term stagnant price performance.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing significant market attention following the FDA approval of Lumvoa for thyroid eye disease, with the community actively debating the drug's commercial potential against established competitors like Tepezza. Discussion is heavily focused on the company's immediate launch strategy, the significance of the broad label covering both active and chronic disease, and whether current valuation levels account for this pivotal commercial milestone.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is seeing heightened activity as community members debate its aggressive share buyback strategy, institutional ownership levels, and a potential partnership with SpaceX to enhance mobile offerings. While some investors view the stock's significant decline as an undervalued entry point, others remain skeptical, focusing on the company's substantial debt load and stiff competition from satellite internet providers.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense market volatility and high trading volume, with the community actively debating whether the price action represents a potential short squeeze or a recurring pump-and-dump cycle. Investors remain divided, with some highlighting the project's potential for rapid recovery while others express concern over liquidity and a perceived lack of developer communication.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corp is trending as investors aggressively position ahead of a critical patent litigation ruling, with strong bullish sentiment fueled by robust adoption metrics for its Yutrepia product. Community discussion remains heavily focused on the stock's massive long-term outperformance compared to peers and speculation that a favorable court decision could trigger significant upside or an acquisition.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as investors cheer positive subcutaneous data for its core drug, fueling speculation about a potential buyout as clinical milestones for broader applications like myasthenia gravis continue to impress. The community is heavily focused on the stock's strong relative strength and the significant pressure building on short sellers, with many long-term shareholders actively debating whether an acquisition is imminent or if further growth will push the valuation into triple digits.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is surging as investors pivot toward AI infrastructure, specifically focusing on the critical bottleneck of data center power capacity. Community discussion is heavily driven by the company's role in providing on-site, behind-the-meter energy solutions for hyperscalers and its recent technical breakout, with many traders debating valuation against the backdrop of an aggressive AI super-cycle.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum is capturing significant attention as investors monitor its debut alongside recent executive orders and government funding initiatives that are elevating the entire quantum computing sector. While the community is actively debating the company's valuation and IPO performance relative to established peers, traders are closely watching how institutional capital and broader market sentiment impact this new, high-volatility entry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?

Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, NUVL, AXTA, and PFLC PR Newswire NEW YORK, June 24, 2026 NEW YORK, June 24, 2026 /PRNewswire/ -- Class...

GSK Commences Tender Offer To Acquire Nuvalent For $124 Per Share

(RTTNews) - GSK plc (GSK) said Wednesday that its indirect wholly-owned subsidiary, Harmony Row Acquisition Co., has commenced a tender offer to acquire all outstanding shares of Nuvalent Inc. (NUVL) for $124.00 per share in cash...

Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders?

Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders? Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 22, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Are NUVL, DAN, PAYO Obtaining Fair Deals for their Shareholders?

Are NUVL, DAN, PAYO Obtaining Fair Deals for their Shareholders? Are NUVL, DAN, PAYO Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 18, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS PR Newswire NEW YORK, June 17, 2026 NEW YORK, June 17, 2026 /PRNewswire/ -- Class...

Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?

Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders? Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 12, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Nuvalent, Inc. (NasdaqGS: NUVL) to GSK plc (NYSE: GSK). Under the terms of the proposed transaction, shareholders of Nuvalent will receive $124.00...

Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, June 10, 2026 MILWAUKEE, June 10, 2026...

Super Micro Computer, Draftkings, Cracker Barrel, Nuvalent And Oracle: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indexes finished Tuesday mixed, with the Dow Jones Industrial Average gaining 0.17% to 50,872.11.read more...

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Nuvalent Inc - Ordinary Shares - Class A

NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$123.52
Prev Close	$123.53
Open	$123.56
Dividend Yield	0.00%
50-Day Moving Average	$107.57
Beta	1.12
Avg. Volume	552,856.86
PE Ratio	-20.39

52-Week High	$123.69
52-Week Low	$71.13
Market Capitalization	$9.76B
EPS (Annual)	-$5.85
Price to Book	8.30
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

NUVLNuvalent Inc - Ordinary Shares - Class A

Latest NUVL News